August 18, 2022
ACNE TREATMENT CONTINUES TO INCREASE IN DEMAND
Recent studies from 2021 state that over 85% of the population suffers from acne at one point or another in their lives.
The main causes of acne formation are increased production of sebum (“seborrheic dermatitis”) as a result of high levels of androgenic hormones, hyperkeratosis of the hair follicles, as well as changes in the natural flora of bacteria and inflammatory processes.
The acne medicine market in the US is estimated at $2 billion: It is no surprise that the demand for acne treatment is increasing, alongside new drugs and technologies. At the same time, acne can be treated without cortisol or medication.
This post is a clinical study summary of the effectiveness of acne treatment using the Alpha device, and without hormones, cortisol or drugs that endanger the liver, especially in adolescence.
ACNE TREATMENT IN JUST 6 WEEKS
Read our findings of a clinical study, conducted for Alpha IPL treatment of acne, in women of child bearing age. The results point to two main benefits of using Alpha: treating acne with Alpha has been proven to be more careful and much more effective. This is the first study to our knowledge in which energy was delivered in continuous and double pulse modes, one after the other, on the same day for six treatment sessions without any adverse effects.
In this study, we assessed the efficacy and safety of IPL therapy (magma-F-SR; FormaTK Systems) to 3 and 4 acne grades in women of child bearing age. A total of 100 women participated in this study, 7 dropped out and 93 remained. We used IPL therapy as the monotherapy for the treatment of inflammatory acne.
WHAT FINDINGS HAVE WE DISCOVERED ABOUT THE EFFECTIVENESS OF IPL?
IPL acts by multiple mechanisms of actions in acne:
- It reduces the inflammation and sebaceous gland size
- It prevents occurrence of new lesions after three weeks of treatment.
- It Increases the amount of dermal collagen and elastic fibers.
- It assists in Uniformly lesion to heal, with no scar formation.
Besides 4 patients who developed mild erythema after the 2nd treatment session, there were no long-term or severe adverse events